Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia.
about
A novel experimental model of Cryptococcus neoformans-related immune reconstitution inflammatory syndrome (IRIS) provides insights into pathogenesis.All-trans retinoic acid in combination with primaquine clears pneumocystis infectionMyeloid-derived suppressor cells impair alveolar macrophages through PD-1 receptor ligation during Pneumocystis pneumonia.Imaging flow cytometry analysis of intracellular pathogens.Immune Modulation as Adjunctive Therapy for Pneumocystis pneumonia.Pneumocystis infection alters the activation state of pulmonary macrophages.Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression.Differential Macrophage Polarization from Pneumocystis in Immunocompetent and Immunosuppressed Hosts: Potential Adjunctive Therapy during PneumoniaNeither classical nor alternative macrophage activation is required for Pneumocystis clearance during immune reconstitution inflammatory syndrome.B cells modulate systemic responses to Pneumocystis murina lung infection and protect on-demand hematopoiesis via T cell-independent innate mechanisms when type I interferon signaling is absent.Modulation of inflammasome-mediated pulmonary immune activation by type I IFNs protects bone marrow homeostasis during systemic responses to Pneumocystis lung infection.Selective ablation of lung epithelial IKK2 impairs pulmonary Th17 responses and delays the clearance of Pneumocystis.A Genome-Wide Search for Bipolar Disorder Risk Loci Modified by Mitochondrial Genome Variation.Intrinsic Programming of Alveolar Macrophages for Protective Antifungal Innate Immunity Against Infection
P2860
Q30379272-6762102C-6758-491E-A2FE-27B27182A0E0Q34545112-AA4CC5A7-6205-4983-9976-3C6848BF7090Q34955808-84BE87EE-0B49-46BE-90F0-88C889493DFDQ36136833-8C869869-8F10-4C9E-8C64-07B558A17D4EQ37929578-5AB343E9-1E68-4F62-984B-4E5CA92D22F0Q39308787-E13EB6FA-CB53-4243-A6BA-AAB5F5A113F3Q40396288-91C9B087-0414-4A24-9C73-089EA3B224E9Q40403699-BEC5A556-DA6F-4548-BBCD-65B2C47C2C27Q40538969-29161A9D-1155-4D5C-A743-F61126A94136Q41632240-5B7302E9-FF15-41C8-A49B-E6EB44A3CC7EQ41985907-85C456CB-F6B7-457F-BAE8-6A7FE7CD236BQ42929667-7CD8B645-D77A-42E7-8876-999CDFA886FFQ53423408-EA253D42-3C0F-45B5-8A7A-8E169DCAA48FQ57072677-A7727EDF-490B-44D0-89C9-0F37D6ED5789
P2860
Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Immune modulation with sulfasa ...... during Pneumocystis pneumonia.
@ast
Immune modulation with sulfasa ...... during Pneumocystis pneumonia.
@en
type
label
Immune modulation with sulfasa ...... during Pneumocystis pneumonia.
@ast
Immune modulation with sulfasa ...... during Pneumocystis pneumonia.
@en
prefLabel
Immune modulation with sulfasa ...... during Pneumocystis pneumonia.
@ast
Immune modulation with sulfasa ...... during Pneumocystis pneumonia.
@en
P2093
P2860
P1433
P1476
Immune modulation with sulfasa ...... during Pneumocystis pneumonia.
@en
P2093
Francis Gigliotti
Samir P Bhagwat
Terry W Wright
Thaddeus C George
P2860
P304
P356
10.1371/JOURNAL.PPAT.1001058
P577
2010-08-19T00:00:00Z